Key Considerations for Developing and Integrating Patient Perspectives in Drug Development: Examination of the Duchenne Case Study
 |
 |
The Biotechnology Innovation Organization (BIO) and Parent Project Muscular Dystrophy (PPMD) teamed up to share best practices for the development of disease-specific patient preference studies based off of the PPMD experience. The paper outlines key considerations to help guide stakeholders on the development of patient preference studies and the multitude of ways they can be used, including to help inform the drug development and regulatory processes.
Read more about the launch of the initiative here.